Publication Information

{'id': 'https://openalex.org/W2358450743', 'doi': None, 'title': 'Comparison of gefitinib and pemetrexed in treatment of advanced non-small cell lung cancer patients who have failed to first-line chemotherapy', 'display_name': 'Comparison of gefitinib and pemetrexed in treatment of advanced non-small cell lung cancer patients who have failed to first-line chemotherapy', 'publication_year': 2012, 'publication_date': '2012-01-01', 'ids': {'openalex': 'https://openalex.org/W2358450743', 'mag': '2358450743'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-YLZL201205020.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764721185', 'display_name': 'Zhongguo linchuang yaolixue yu zhiliaoxue', 'issn_l': '1009-2501', 'issn': ['1009-2501'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4361727491', 'host_organization_name': 'Chinese Pharmacological Society', 'host_organization_lineage': ['https://openalex.org/P4361727491'], 'host_organization_lineage_names': ['Chinese Pharmacological Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5064735840', 'display_name': 'Guangyue Qin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210119853', 'display_name': 'Zhejiang Hospital', 'ror': 'https://ror.org/02kzr5g33', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210119853']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Qin Guang-yue', 'raw_affiliation_strings': ['Department of Respiratory,Zhejiang Hospital,Hangzhou 310013,Zhejiang,China'], 'affiliations': [{'raw_affiliation_string': 'Department of Respiratory,Zhejiang Hospital,Hangzhou 310013,Zhejiang,China', 'institution_ids': ['https://openalex.org/I4210119853']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5064735840'], 'corresponding_institution_ids': ['https://openalex.org/I4210119853'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10202', 'display_name': 'Lung Cancer Diagnosis and Treatment', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Colorectal Cancer Treatments and Studies', 'score': 0.9899, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pemetrexed', 'display_name': 'Pemetrexed', 'score': 0.98635256}], 'concepts': [{'id': 'https://openalex.org/C2777240266', 'wikidata': 'https://www.wikidata.org/wiki/Q415220', 'display_name': 'Pemetrexed', 'level': 4, 'score': 0.98635256}, {'id': 'https://openalex.org/C2780580887', 'wikidata': 'https://www.wikidata.org/wiki/Q417824', 'display_name': 'Gefitinib', 'level': 4, 'score': 0.86814487}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8485936}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.78658426}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.7601092}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.72880036}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6773871}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3310036}, {'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.21905711}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.09053755}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-YLZL201205020.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764721185', 'display_name': 'Zhongguo linchuang yaolixue yu zhiliaoxue', 'issn_l': '1009-2501', 'issn': ['1009-2501'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4361727491', 'host_organization_name': 'Chinese Pharmacological Society', 'host_organization_lineage': ['https://openalex.org/P4361727491'], 'host_organization_lineage_names': ['Chinese Pharmacological Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'AIM:To': [0], 'evaluate': [1], 'the': [2, 60, 70, 90, 124, 142], 'clinical': [3], 'difference': [4, 58, 88, 140], 'between': [5, 59, 89, 141], 'gefitinib': [6, 35, 61], 'and': [7, 48, 62, 137], 'pemetrexed': [8, 37, 63, 77, 116], 'in': [9, 93, 123], 'treatment': [10, 130], 'of': [11, 131], 'advanced': [12, 100], 'non-small': [13], 'cell': [14], 'lung': [15], 'cancer(NSCLC)': [16], 'patients': [17, 30, 75, 83, 98, 114], 'who': [18, 33, 102], 'have': [19, 103], 'failed': [20, 104], 'to': [21, 27, 105], 'first-line': [22, 106], 'chemotherapy.METHODS:': [23], 'From': [24], 'Feb': [25], '2009': [26], 'Oct': [28], '2011,64': [29], 'with': [31, 99, 129], 'NSCLC': [32, 101], 'received': [34, 76, 84, 115], 'or': [36], 'for': [38, 65, 74, 113, 119], 'second': [39, 125], 'line': [40, 126], 'chemotherapy': [41, 127], 'were': [42, 52], 'analysised': [43], 'retrospectively.The': [44], 'progression': [45, 66, 120], 'survival': [46, 50, 68, 72, 109], 'time': [47, 51, 73, 110, 122], 'overall': [49, 71, 108], 'evaluated.': [53], 'RESULTS:There': [54], 'was': [55, 78, 111, 135, 145], 'no': [56, 138], 'statistics': [57], 'group': [64, 92], 'free': [67, 121], 'time(HR=1.21,95%CI:0.68-2.16,χ2=0.41,P=0.52).But': [69], 'much': [79], 'longer': [80, 112], 'than': [81], 'that': [82], 'gefinitib(HR=1.99': [85], '95%CI:1.04-3.85,χ2=4.30,P=0.04).No': [86], 'statistical': [87, 139], 'two': [91, 143], 'side': [94, 133], 'effect(P0.05).': [95], 'CONCLUSION:': [96], 'For': [97], 'chemotherapy,the': [107], 'but': [117], 'not': [118], 'compared': [128], 'pemetrexed.The': [132], 'effect': [134], 'acceptable': [136], 'groups': [144], 'observed.': [146]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2358450743', 'counts_by_year': [], 'updated_date': '2024-12-08T07:17:39.985706', 'created_date': '2016-06-24'}